Pharma Marketing Network

Featured Conference Optimizing the Use of Patient-Level Data (PLD) to Enhance Your Marketing Capabilities March 22-23,...

Featured Conference 2nd Annual Gaining Physician Access March 22-23, 2004 * Philadelphia, PA...

So, the economy sucks and there's less low hanging fruit to go after. That's life. In order to deal with the hand we've been dealt and get our share of the available crumbs out there, we really can't afford to have marketing that sucks. We have to engage in some extreme marketing

New Written Prescriptions (NWRx's), which are uncontaminated by managed care intervention and patient fulfillment issues, are the ultimate measure of physician behavior and, therefore, the purest measure of promotional effectiveness, according to Nancy S. Lurker, CEO of ImpactRx. This article highlights real world examples of the differences between analyses performed using ImpactRx's NWRx's for patients new to or switching therapy versus those using traditional dispensed new prescription data.

Speaking on the topic of marketing at the Strategic Research Institute's 2nd Pharmaceutical Marketing Global Summit held in Philadelphia, PA, February 26, 2004, Stevens offered advice for pharmaceutical marketers on how not to make their marketing suck.

This article summaries a presentation made by Diane Stafford, Head of Patient Relationship Marketing for Pfizer UK at a recent industry conference. In her presentation, entitled 'The E-nabled Patient: Using Technology to help build valuable patient relationships,' Ms. Stafford demonstrated how to implement 1-to-1 electronic relationships to deliver improved compliance, analyzed emerging new compliance initiatives using technology, and discussed successful approaches to develop patient 'loyalty' programmes and demonstrated their value.

Patient compliance may be a core objective for pharma marketers, but an international quorum of compliance experts at the recent eyeforpharma Patient Compliance 2004 conference in London agreed that the very term 'compliance is incorrect. In 22 in-depth presentations over 2 days, 30 speakers and panelists agreed that marketers need to stop analyzing compliance, and start understanding patients.

Patient compliance may be a core objective for pharma marketers, but an international quorum of compliance experts at the recent eyeforpharma Patient Compliance 2004 conference in London agreed that the very term 'compliance is incorrect. In 22 in-depth presentations over 2 days, 30 speakers and panelists agreed that marketers need to stop analyzing compliance, and start understanding patients.

This article, which is a review of the seminar, Best Practices for Medical Science Liaisons (MSLs) held in Princeton, New Jersey, in January, 2004, highlights how MSLs can maximize their unique position to help improve medical care while they enhance their companies' bottom lines.

Key external drivers shaping the short and longer-term futures of pharma, including political, economic, the provider market, plans, payers/employers, and e-business, among them. How to plan for scenarios based on these drivers.